Serum transgelin is a novel prognostic biomarker for COVID-19 patients
BackgroundTransgelin is a central actin-binding protein of the calponin family and involved in the process of multiple pulmonary diseases. Nevertheless, the role of transgelin in Coronavirus disease 2019 (COVID-19) patients is confusing.MethodsAll 317 COVID-19 patients were recruited from two hospit...
Saved in:
| Main Authors: | Lei Gao, Ying Liu, Qi-Yuan He, Yu Wang, Ya-Lin Jiang, Jin Yang, Lin Fu, Hui Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1423182/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Serum Irisin With Severity and Prognosis in Patients With Coronavirus Disease 2019: A Prospective Cohort Study
by: Zhang X, et al.
Published: (2025-02-01) -
Relationship between serum Midkine and Omentin-1 levels and the severity of sepsis in patients and their prognostic value
by: Lin Gao, et al.
Published: (2024-12-01) -
Unveiling the role of transgelin as a prognostic and therapeutic target in kidney fibrosis via a proteomic approach
by: Soie Kwon, et al.
Published: (2024-10-01) -
Prognostic value of serum HDAC2 and sST2 in occupational asthma patients
by: Ruifeng FENG, et al.
Published: (2024-11-01) -
Prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in American adults with hypertension: results from the NHANES database
by: Jing Tang, et al.
Published: (2025-01-01)